Deborah Ascheim
CIK 1649531 · View on SEC EDGAR ↗
First SEC filing: July 25, 2018 · Latest: July 25, 2018
On this page
- Insider at Companies where this person is a reporting insider.
- Insider transactions Every share this person bought or sold, from Form 4 filings.
- Derivatives Options and other derivative holdings reported by this person.
- Initial holdings The stakes this person held when they first started reporting.
- Compensation Executive pay disclosed in company proxy statements.
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| July 24, 2018 | CAPR | A | 50,000 | — | — | 50,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 2, 2018 | CAPR | A | 43,122 | — | — | 43,122 Direct | — | Acquired | (price as of 2026-08-21) |
| Jan. 3, 2017 | CAPR | A | 50,000 | — | — | 50,000 Direct | — | Acquired | (price as of 2026-08-21) |
| Sept. 18, 2015 | CAPR | A | 130,000 | — | — | 130,000 Direct | — | Acquired | (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| July 24, 2018 | CAPR | Stock Option (right to buy) | Common Stock (50,000) | $1.24 | July 24, 2018 | 50,000 | Acquired |
| Jan. 2, 2018 | CAPR | Stock Option (right to buy) | Common Stock (43,122) | $1.57 | Jan. 2, 2028 | 43,122 | Acquired |
| Jan. 3, 2017 | CAPR | Stock Option (right to buy) | Common Stock (50,000) | $2.55 | Jan. 3, 2027 | 50,000 | Acquired |
| Sept. 18, 2015 | CAPR | Stock Option (right to buy) | Common Stock (130,000) | $4.34 | Sept. 18, 2025 | 130,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).
Initial ownership (Form 3) 1 holding
Securities held when first becoming an insider, per SEC Form 3.
| Date | Ticker | Security | Shares | Ownership |
|---|---|---|---|---|
| July 13, 2026 | LGVN | Class A Common Stock | 0 | Direct |
Compensation (DEF 14A)
Matched by name from proxy statements (DEF 14A) — verify against the filing.
CAPR
M.D.(3) Former Chief Medical Officer| Fiscal year | Salary | Bonus | Stock awards | Option awards | Non-equity incentive | Pension change | Other | Total |
|---|---|---|---|---|---|---|---|---|
| 2018 | $244,451 | — | — | $119,446 | — | — | $1,000 | $364,897 |
| 2017 | $255,000 | — | — | $92,300 | — | — | $1,000 | $348,300 |
| 2014 | — | — | — | — | — | — | — | — |
Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.